• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人格障碍:综述及在日常临床实践中的应用。

Personality disorders: review and clinical application in daily practice.

机构信息

Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

出版信息

Am Fam Physician. 2011 Dec 1;84(11):1253-60.

PMID:22150659
Abstract

Personality disorders have been documented in approximately 9 percent of the general U.S. population. Psychotherapy, pharmacotherapy, and brief interventions designed for use by family physicians can improve the health of patients with these disorders. Personality disorders are classified into clusters A, B, and C. Cluster A includes schizoid, schizotypal, and paranoid personality disorders. Cluster B includes borderline, histrionic, antisocial, and narcissistic personality disorders. Cluster C disorders are more prevalent and include avoidant, dependent, and obsessive-compulsive personality disorders. Many patients with personality disorders can be treated by family physicians. Patients with borderline personality disorder may benefit from the use of omega-3 fatty acids, second-generation antipsychotics, and mood stabilizers. Patients with antisocial personality disorder may benefit from the use of mood stabilizers, antipsychotics, and antidepressants. Other therapeutic interventions include motivational interviewing and solution-based problem solving.

摘要

人格障碍在大约 9%的美国普通人群中得到了记录。心理治疗、药物治疗和为家庭医生设计的简短干预措施可以改善这些障碍患者的健康状况。人格障碍分为 A、B 和 C 型。A 型包括分裂样、分裂型和偏执型人格障碍。B 型包括边缘型、表演型、反社会型和自恋型人格障碍。C 型障碍更为常见,包括回避型、依赖型和强迫型人格障碍。许多人格障碍患者可以由家庭医生治疗。边缘型人格障碍患者可能受益于使用ω-3 脂肪酸、第二代抗精神病药和情绪稳定剂。反社会人格障碍患者可能受益于使用情绪稳定剂、抗精神病药和抗抑郁药。其他治疗干预措施包括动机访谈和基于解决方案的问题解决。

相似文献

1
Personality disorders: review and clinical application in daily practice.人格障碍:综述及在日常临床实践中的应用。
Am Fam Physician. 2011 Dec 1;84(11):1253-60.
2
[Personality disorders in a nonclinical sample of adolescents].[青少年非临床样本中的人格障碍]
Encephale. 2002 Nov-Dec;28(6 Pt 1):520-4.
3
Assessment and management of personality disorders.人格障碍的评估与管理。
Am Fam Physician. 2004 Oct 15;70(8):1505-12.
4
[Psychopathy and associated personality disorders: searching for a particular effect of the borderline personality disorder?].[精神病态及相关人格障碍:探寻边缘型人格障碍的特殊影响?]
Encephale. 2010 Jun;36(3):253-9. doi: 10.1016/j.encep.2009.07.004. Epub 2009 Sep 26.
5
Personality disorders.人格障碍
Am Fam Physician. 1983 Mar;27(3):215-23.
6
The graying of personality disorders: persistent, but different.人格障碍的老龄化:持续存在,但有所不同。
Consult Pharm. 2007 Dec;22(12):995-1003. doi: 10.4140/tcp.n.2007.995.
7
The comorbidity of multiple personality disorder and DSM-III-R axis II disorders.多重人格障碍与《精神疾病诊断与统计手册第三版修订本》轴II障碍的共病情况。
Psychiatr Clin North Am. 1991 Sep;14(3):547-66.
8
[Personality disorder].[人格障碍]
Rev Prat. 2008 Mar 15;58(5):551-6; quiz 575.
9
Rorschach aggression variables: a study of reliability and validity.罗夏测验攻击变量:信度与效度研究
J Pers Assess. 1999 Feb;72(1):93-110. doi: 10.1207/s15327752jpa7201_6.
10
Screening of personality disorders among chinese college students by Personality Diagnostic Questionnaire-4+.使用《人格诊断问卷-4+》对中国大学生进行人格障碍筛查。
J Pers Disord. 2007 Aug;21(4):448-54. doi: 10.1521/pedi.2007.21.4.448.

引用本文的文献

1
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study.伴有共病人格和心理障碍的耐药性偏头痛患者的外周内源性大麻素成分和脂质血浆水平:一项横断面研究。
Int J Mol Sci. 2024 Feb 4;25(3):1893. doi: 10.3390/ijms25031893.
2
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study.依瑞奈玛单抗治疗慢性偏头痛疗效不佳的心理预测因素:一项开放标签长期前瞻性研究的数据。
J Headache Pain. 2021 Oct 2;22(1):114. doi: 10.1186/s10194-021-01333-4.
3
Mental health dished up-the use of iPSC models in neuropsychiatric research.
精神健康上桌- iPSC 模型在神经精神研究中的应用。
J Neural Transm (Vienna). 2020 Nov;127(11):1547-1568. doi: 10.1007/s00702-020-02197-9. Epub 2020 May 7.
4
Review of pharmacologic treatment in cluster A personality disorders.A 类人格障碍的药物治疗综述
Ment Health Clin. 2016 Mar 8;6(2):75-81. doi: 10.9740/mhc.2016.03.75. eCollection 2016 Mar.
5
Collaborative Care Management Associated With Improved Depression Outcomes in Patients With Personality Disorders, Compared to Usual Primary Care.与常规初级护理相比,协作式护理管理与人格障碍患者抑郁症状改善相关。
J Prim Care Community Health. 2018 Jan-Dec;9:2150132718773266. doi: 10.1177/2150132718773266.
6
The Potential Role of Naltrexone in Borderline Personality Disorder.纳曲酮在边缘型人格障碍中的潜在作用。
Iran J Psychiatry. 2017 Apr;12(2):142-146.
7
Personality Disorders in Primary Care: Impact on Depression Outcomes Within Collaborative Care.初级保健中的人格障碍:对协作护理中抑郁症治疗结果的影响
J Prim Care Community Health. 2017 Oct;8(4):233-238. doi: 10.1177/2150131917714929. Epub 2017 Jun 14.